The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Clinical and economic impact of antibiotic resistance in developing countries: A systematic review and meta-analysis
Open accessAbstract
INTRODUCTION: Despite evidence of the high prevalence of antibiotic resistant infections in developing countries, studies on the clinical and economic impact of antibiotic resistance (ABR) to inform interventions to contain its emergence and spread are limited. The aim of this study was to analyze the published literature on the clinical and economic implications of ABR in developing countries. METHODS: A systematic search was carried out in Medline via PubMed and Web of Sciences and included studies published from January 01, 2000 to December 09, 2016. All papers were considered and a quality assessment was performed using the Newcastle-Ottawa quality assessment scale (NOS). RESULTS: Of 27 033 papers identified, 40 studies met the strict inclusion and exclusion criteria and were finally included in the qualitative and quantitative analysis. Mortality was associated with resistant bacteria, and statistical significance was evident with an odds ratio (OR) 2.828 (95%CI, 2.231-3.584; p = 0.000). ESKAPE pathogens was associated with the highest risk of mortality and with high statistical significance (OR 3.217; 95%CIs; 2.395-4.321; p = 0.001). Eight studies showed that ABR, and especially antibiotic-resistant ESKAPE bacteria significantly increased health care costs. CONCLUSION: ABR is associated with a high mortality risk and increased economic costs with ESKAPE pathogens implicated as the main cause of increased mortality. Patients with non-communicable disease co-morbidities were identified as high-risk populations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & The PRISMA Group (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000097 · Cited by 64,042
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
Dermyshi, E., Wang, Y., Yan, C., Hong, W., Qiu, G., Gong, X., & Zhang, T. (2017) · Neonatology · doi:10.1159/000454668 · Cited by 24,451
Meta-analysis of Observational Studies in Epidemiology<SUBTITLE>A Proposal for Reporting</SUBTITLE>
Stroup, D. F. (2000) · JAMA · doi:10.1001/jama.283.15.2008 · Cited by 20,623
Wang, G., Ma, R., Qiao, G., Wada, K., Aizawa, Y., & Satoh, T. (2015) · Integrative Medicine International · doi:10.1159/000368408 · Cited by 18,657
(2014) · Medical Entomology and Zoology · Cited by 17,633
(2016) · Cited by 2,888
(2015) · Microbe Magazine · doi:10.1128/microbe.10.354.1 · Cited by 2,266
Mechanisms of Antimicrobial Resistance in ESKAPE Pathogens
Santajit, S., & Indrawattana, N. (2016) · BioMed Research International · doi:10.1155/2016/2475067 · Cited by 1,641
Cited by
Antimicrobial Resistance: A Growing Serious Threat for Global Public Health
Salam, M. A., Al-Amin, M. Y., Salam, M. T., Pawar, J. S., Akhter, N., Rabaan, A. A., & Alqumber, M. A. A. (2023) · Healthcare · doi:10.3390/healthcare11131946 · Cited by 2,338
Antimicrobial Resistance: Implications and Costs
Dadgostar, P. (2019) · Infection and Drug Resistance · doi:10.2147/idr.s234610 · Cited by 2,024
“Patient Perspective Morbidity and mortality are important consequences of AMR affecting patients.(1,6) Compared to non-resistant”
BackgroundInfluentialEmerging Strategies to Combat ESKAPE Pathogens in the Era of Antimicrobial Resistance: A Review
Mulani, M. S., Kamble, E. E., Kumkar, S. N., Tawre, M. S., & Pardesi, K. R. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00539 · Cited by 1,644
Muteeb, G., Rehman, M. T., Shahwan, M., & Aatif, M. (2023) · Pharmaceuticals · doi:10.3390/ph16111615 · Cited by 1,215
Wastewater Treatment and Reuse: a Review of its Applications and Health Implications
Kesari, K. K., Soni, R., Jamal, Q. M. S., Tripathi, P., Lal, J. A., Jha, N. K., Siddiqui, M. H., Kumar, P., Tripathi, V., & Ruokolainen, J. (2021) · Water, Air, & Soil Pollution · doi:10.1007/s11270-021-05154-8 · Cited by 638
Antimicrobial Stewardship: Fighting Antimicrobial Resistance and Protecting Global Public Health
Majumder, M. A. A., Rahman, S., Cohall, D., Bharatha, A., Singh, K., Haque, M., & Gittens-St Hilaire, M. (2020) · Infection and Drug Resistance · doi:10.2147/idr.s290835 · Cited by 633
The role of vaccines in combatting antimicrobial resistance
Micoli, F., Bagnoli, F., Rappuoli, R., & Serruto, D. (2021) · Nature Reviews Microbiology · doi:10.1038/s41579-020-00506-3 · Cited by 500
Economic burden of antibiotic resistance in ESKAPE organisms: a systematic review
Zhen, X., Lundborg, C. S., Sun, X., Hu, X., & Dong, H. (2019) · Antimicrobial Resistance & Infection Control · doi:10.1186/s13756-019-0590-7 · Cited by 337
Human campylobacteriosis: A public health concern of global importance
Igwaran, A., & Okoh, A. I. (2019) · Heliyon · doi:10.1016/j.heliyon.2019.e02814 · Cited by 332
Considerations and Caveats in Combating ESKAPE Pathogens against Nosocomial Infections
Ma, Y., Wang, C., Li, Y., Li, J., Wan, Q., Chen, J., Tay, F. R., & Niu, L. (2020) · Advanced Science · doi:10.1002/advs.201901872 · Cited by 314
Bacterial Resistance to Antimicrobial Agents
Varela, M. F., Stephen, J., Lekshmi, M., Ojha, M., Wenzel, N., Sanford, L. M., Hernandez, A. J., Parvathi, A., & Kumar, S. H. (2021) · Antibiotics · doi:10.3390/antibiotics10050593 · Cited by 292
An Overview of the Recent Advances in Antimicrobial Resistance
Oliveira, M., Antunes, W., Mota, S., Madureira-Carvalho, Á., Dinis-Oliveira, R. J., & Dias da Silva, D. (2024) · Microorganisms · doi:10.3390/microorganisms12091920 · Cited by 285
The economic burden of antibiotic resistance: A systematic review and meta-analysis
Poudel, A. N., Zhu, S., Cooper, N., Little, P., Tarrant, C., Hickman, M., & Yao, G. (2023) · PLOS ONE · doi:10.1371/journal.pone.0285170 · Cited by 264
Godman, B., Haque, M., McKimm, J., Abu Bakar, M., Sneddon, J., Wale, J., Campbell, S., Martin, A. P., Hoxha, I., Abilova, V., et al. (2020) · Current Medical Research and Opinion · doi:10.1080/03007995.2019.1700947 · Cited by 171
Alrasheedy, A. A., Alsalloum, M. A., Almuqbil, F. A., Almuzaini, M. A., Aba Alkhayl, B. S., Albishri, A. S., Alharbi, F. F., Alharbi, S. R., Alodhayb, A. K., Alfadl, A. A., et al. (2020) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2020.1705156 · Cited by 102
Wang, S., Chen, L., Ran, H., Che, Y., Fang, D., Sun, H., Peng, J., Liang, X., & Xiao, Y. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.917552 · Cited by 94
Saleem, Z., Hassali, M. A., Hashmi, F. K., Godman, B., & Saleem, F. (2019) · Family Medicine and Community Health · doi:10.1136/fmch-2019-000138 · Cited by 77
Belachew, S. A., Hall, L., Erku, D. A., & Selvey, L. A. (2021) · BMC Public Health · doi:10.1186/s12889-021-11163-3 · Cited by 73
Fu, Y., Dou, Q., Smalla, K., Wang, Y., Johnson, T. A., Brandt, K. K., Mei, Z., Liao, M., Hashsham, S. A., Schäffer, A., et al. (2023) · mLife · doi:10.1002/mlf2.12101 · Cited by 65
Musila, L., Kyany’a, C., Maybank, R., Stam, J., Oundo, V., & Sang, W. (2021) · PLOS ONE · doi:10.1371/journal.pone.0246937 · Cited by 55
Implications of non-prescription antibiotic sales in China
Kalungia, A., & Godman, B. (2019) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(19)30408-6 · Cited by 47
Artificial Intelligence to Improve Antibiotic Prescribing: A Systematic Review
Amin, D., Garzόn-Orjuela, N., Garcia Pereira, A., Parveen, S., Vornhagen, H., & Vellinga, A. (2023) · Antibiotics · doi:10.3390/antibiotics12081293 · Cited by 34
Ahmed, H., Zolfo, M., Williams, A., Ashubwe-Jalemba, J., Tweya, H., Adeapena, W., Labi, A.-K., Adomako, L. A. B., Addico, G. N. D., Banu, R. A., et al. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph191912300 · Cited by 32
“Studies documenting AMR in water are primarily from developed countries, mostly Europe, with a gap in knowledge from LMICs [4].”
BackgroundGebregziabher, N. K., Netsereab, T. B., Franchesko, B. T., Ghebreamlak, H. H., & Yihdego, N. M. (2024) · Antimicrobial Resistance & Infection Control · doi:10.1186/s13756-024-01466-6 · Cited by 23
“The economic burden of antibiotic resistance is also substantial, with countries facing increased healthcare costs and lost productivity [6–8].”
BackgroundEpidemiology of Staphylococcus aureus Infections in Kenya: Current State, Gaps and Opportunities
Nyasinga, J., Omuse, G., John, N., Nyerere, A., Abdulgader, S., Newton, M., Whitelaw, A., & Revathi, G. (2020) · Open Journal of Medical Microbiology · doi:10.4236/ojmm.2020.104018 · Cited by 14
Assessment of rationality of available fixed dose combinations of antibiotics in India
Anand, P., Kaur, N., Verma, V., Shafiq, N., & Malhotra, S. (2022) · Expert Review of Anti-Infective Therapy · doi:10.1080/14787210.2022.2015324 · Cited by 13
Founou, R. C., Founou, L. L., Allam, M., Ismail, A., & Essack, S. Y. (2020) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2020.05.012 · Cited by 7
Self-citation
Metadata
- Authors
- Founou, R. C., Founou, L. L., & Essack, S. Y.
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2017-12-21
- Volume
- 12
- Issue
- 12
- Pages
- e0189621
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2778896509
- Cited by
- 710
- References
- 52
- FWCI
- 5.95
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.